NEW DELHI: Antibiotics used to treat common bacterial infections are increasingly losing their effectiveness, with a new Indian Council of Medical Research (ICMR) report finding only 18.4% of E. coli samples tested in hospitals were susceptible to cefotaxime, an antibiotic used to treat serious infections such as pneumonia and UTIs.The findings come at a time when govt is drawing attention to the misuse of antibiotics. At the launch of World Antimicrobial Resistance Awareness Week (Nov 18), the health ministry highlighted concerns over antibiotic sales without prescriptions and inappropriate prescribing.ICMR’s Antimicrobial Resistance Surveillance and Research Network annual report for 2025 also found high resistance to stronger antibiotics used to treat severe infections. Only around one-third of Klebsiella pneumoniae samples were susceptible to carbapenems, powerful antibiotics often reserved for serious infections that do not respond to other medicines.
Share your thoughts in the comments
Be respectful · TOI community guidelines
Another finding was 91.1% of revived Acinetobacter baumannii isolates tested were resistant to carbapenems. This can cause serious hospital-acquired infections, particularly pneumonia and bloodstream infections among critically ill patients.Dr Kamini Walia, head of ICMR’s descriptive research division, said the findings showed antimicrobial resistance was not confined to large referral centres. Citing the secondary-care hospital data, she said ceftriaxone susceptibility in E. coli declined from 39.8% in category I hospitals to 28% in category II and just 11.5% in category III.













